Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE182765
下载链接
链接失效反馈官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2022-10-20
相关数据集
Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease. Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem10
Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT01_J20_apoEKI_Bumex_snRNA-seq]. Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT01_J20_apoEKI_Bumex_snRNA-seq]
The evident genetic, pathological, and clinical heterogeneity of Alzheimer’s disease (AD) poses challenges for traditional drug development. We conducted a computational drug repurposing screen for dr
NIAID Data Ecosystem20
Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT2123B_iPS_Bumex_RNA-seq]
The evident genetic, pathological, and clinical heterogeneity of Alzheimer’s disease (AD) poses challenges for traditional drug development. We conducted a computational drug repurposing screen for dr
NIAID Data Ecosystem40
Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT2123B_iPS_Bumex_RNA-seq]. Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT2123B_iPS_Bumex_RNA-seq]
The evident genetic, pathological, and clinical heterogeneity of Alzheimer’s disease (AD) poses challenges for traditional drug development. We conducted a computational drug repurposing screen for dr
NIAID Data Ecosystem20
Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT02_apoE4KI_Bumex_snRNA-seq]. Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT02_apoE4KI_Bumex_snRNA-seq]
The evident genetic, pathological, and clinical heterogeneity of Alzheimer’s disease (AD) poses challenges for traditional drug development. We conducted a computational drug repurposing screen for dr
NIAID Data Ecosystem20
